STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
EIGR EIGER BIOPHARMACEUTICALS INCORPORATED StockScouter® Report
4
StockScouter® Score
EIGER BIOPHARMACEUTICALS INCORPORATED, a micro cap value company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year has accelerated moderately compared to earnings growth in the past three years. Positive
- The enterprise value-to-sales ratio is lower than the average for comparably-sized companies in the StockScouter universe. Positive
Concerns
- Moving average analysis for EIGR suggests weak price movement over the medium term. Negative
- Short-term relative price momentum exhibits meaningful weakness. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that micro cap stocks will be neutral, value stocks will be neutral, and healthcare stocks will be neutral.
Expected Risk/Return
Core Model Grades
C
C
B
C